Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients
Open Access
- 1 January 2020
- journal article
- research article
- Published by Informa UK Limited in Emerging Microbes & Infections
- Vol. 9 (1), 833-836
- https://doi.org/10.1080/22221751.2020.1756699
Abstract
Effective strategy to mitigate the ongoing pandemic of 2019 novel coronavirus (COVID-19) require a comprehensive understanding of humoral responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the emerging virus causing COVID-19. The dynamic profile of viral replication and shedding along with viral antigen specific antibody responses among COVID-19 patients started to be reported but there is no consensus on their patterns. Here, we conducted a serial investigation on 21 individuals infected with SARS-CoV-2 in two medical centres from Jiangsu Province, including 11 non-severe COVID-19 patients, and 5 severe COVID-19 patients and 5 asymptomatic carriers based on nucleic acid test and clinical symptoms. The longitudinal swab samples and sera were collected from these people for viral RNA testing and antibody responses, respectively. Our data revealed different pattern of seroconversion among these groups. All 11 non-severe COVID-19 patients and 5 severe COVID-19 patients were seroconverted during hospitalization or follow-up period, suggesting that serological testing is a complementary assay to nucleic acid test for those symptomatic COVID-19 patients. Of note, immediate antibody responses were identified among severe cases, compared to non-severe cases. On the other hand, only one were seroconverted for asymptomatic carriers. The SARS-CoV-2 specific antibody responses were well-maintained during the observation period. Such information is of immediate relevance and would assist COVID-19 clinical diagnosis, prognosis and vaccine design.Keywords
Funding Information
- National Natural Science Foundation of China (81471994,81600201,81871734)
This publication has 14 references indexed in Scilit:
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaThe New England Journal of Medicine, 2020
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting WuhanEmerging Microbes & Infections, 2020
- Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severityEmerging Microbes & Infections, 2020
- Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routesEmerging Microbes & Infections, 2020
- Timely development of vaccines against SARS-CoV-2Emerging Microbes & Infections, 2019
- Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infectionJCI Insight, 2019
- The Multifaceted B Cell Response to Influenza VirusThe Journal of Immunology, 2019
- How specific is too specific? B‐cell responses to viral infections reveal the importance of breadth over depthImmunological Reviews, 2013
- Antibody responses against SARS coronavirus are correlated with disease outcome of infected individualsJournal of Medical Virology, 2005
- Antibody-enhanced dengue virus infection in primate leukocytesNature, 1977